Company: CDT
Filing Date: 2025-07-08
Form Type: DEF 14A
Source: 0001641172-25-018242
Chunk: 44

Company: CDT Equity Inc.
Filing Date: 2025-07-08
Form: DEF 14A
Chunk 44
---
ira”), an entity controlled by Dr. Regan, of which he is the sole director. The Joint Development Agreement has an initial term of one year during which the Company will grant Manoira a royalty-free license to the intellectual property rights related to the pharmaceutical compounds known individually and together as AZD1656 and AZD5658 (“Conduit Assets”). Manoira will evaluate the Conduit Assets’ applicability in animal health, explore veterinary market opportunities, and provide data from evaluations to inform the Company’s human clinical programs. Effective June 3, 2025, in exchange for approximately $500,000 of consideration to be paid by the Company under the Joint Development Agreement, the Company issued to Manoira 154,799 shares of Common Stock, valued at closing price of the Common Stock immediately preceding execution of the Joint Development Agreement.

Directors and Officers

Certain of the individuals that serve as members of our Boardsince completion of the Business Combination have relationships with MURF, Old Conduit, and/or one of their respective stockholders. Chele Chiavacci Farley was a director of MURF and continues to serve on the Company’s Board; upon the completion of the Business Combination, she received 10 shares of Company common stock and 10 redeemable warrants that Murphy Canyon Acquisition Sponsor, LLC transferred to Ms. Chiavacci Farley in consideration of her acting as an independent director of MURF. Dr. Freda Lewis-Hall, the Chairperson of our Board, was an indirect shareholder of Conduit and indirectly received 1,335 shares of our Common Stock upon completion of the Business Combination. Dr. David Tapolczay, our Chief Executive Officer, and a member of our Board for fiscal year ended 2024, was a shareholder of Old Conduit and received 1,335 shares of our Common Stock upon completion of the Business Combination. Dr. Tapolczay is also a director of Old Conduit and he was previously the Chief Executive Officer of St. George Street until September 2023; as of April 2025, Dr. Tapolczay is an employee of Conduit UK Management Ltd. Dr. Andrew Regan, a member of our Board and our chief executive officer as of April 2025, is a director of Old Conduit and received 44 shares of our Common Stock upon completion of the Business Combination. James Bligh, a member of our Board and our interim chief financial officer, was an employee of Old Conduit and currently serves as